Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Comparing presenting clinical features of 48 children with microscopic polyangiitis (MPA) against 183 having granulomatosis with polyangiitis (GPA). An ARChiVe study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins G, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik M, Lawson E, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater H, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas initiative.

Arthritis Rheumatol. 2016 Apr 25. doi: 10.1002/art.39729. [Epub ahead of print]

PMID:
27111558
2.

B-Cell Depletion is Protective Against Anti-AAV Capsid Immune Response: A Human Subject Case Study.

Corti M, Elder M, Falk D, Lawson L, Smith B, Nayak S, Conlon T, Clément N, Erger K, Lavassani E, Green M, Doerfler P, Herzog R, Byrne B.

Mol Ther Methods Clin Dev. 2014;1. pii: 14033.

3.

Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

Huber AM, Mamyrova G, Lachenbruch PA, Lee JA, Katz JD, Targoff IN, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Care Res (Hoboken). 2014 May;66(5):732-40. doi: 10.1002/acr.22212.

4.

The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.

Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jul;92(4):223-43. doi: 10.1097/MD.0b013e31829d08f9.

5.

Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis.

Shah M, Targoff IN, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Arthritis Rheum. 2013 Jul;65(7):1934-41. doi: 10.1002/art.37985.

6.

B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe disease.

Elder ME, Nayak S, Collins SW, Lawson LA, Kelley JS, Herzog RW, Modica RF, Lew J, Lawrence RM, Byrne BJ.

J Pediatr. 2013 Sep;163(3):847-54.e1. doi: 10.1016/j.jpeds.2013.03.002. Epub 2013 Apr 16.

7.

The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group.

Medicine (Baltimore). 2013 Jan;92(1):25-41. doi: 10.1097/MD.0b013e31827f264d.

8.

Acute-onset opioid-induced hyperalgesia in a child with juvenile idiopathic arthritis.

Vijayan V, Moran R, Elder ME, Sukumaran S.

J Clin Rheumatol. 2012 Oct;18(7):349-51. doi: 10.1097/RHU.0b013e31826d2663.

PMID:
23047535
9.

Pompe disease gene therapy.

Byrne BJ, Falk DJ, Pacak CA, Nayak S, Herzog RW, Elder ME, Collins SW, Conlon TJ, Clement N, Cleaver BD, Cloutier DA, Porvasnik SL, Islam S, Elmallah MK, Martin A, Smith BK, Fuller DD, Lawson LA, Mah CS.

Hum Mol Genet. 2011 Apr 15;20(R1):R61-8. doi: 10.1093/hmg/ddr174. Epub 2011 Apr 25. Review.

10.

Detection of single clone deletions using array CGH: identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system.

Tokuyasu TA, Cotter PD, Segraves R, Harris J, Elder ME, Gonzales M, Pinkel D, Albertson DG, Rauen KA.

Am J Med Genet A. 2007 May 1;143A(9):925-32.

PMID:
17394204
11.
12.

Thrombosis and pediatric Wegener's granulomatosis: acquired and genetic risk factors for hypercoagulability.

von Scheven E, Lu TT, Emery HM, Elder ME, Wara DW.

Arthritis Rheum. 2003 Dec 15;49(6):862-5. No abstract available.

13.

Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, Sutter RW.

J Infect Dis. 2003 Dec 15;188(12):1845-52. Epub 2003 Dec 8.

14.
15.

T-cell immunodeficiencies.

Elder ME.

Pediatr Clin North Am. 2000 Dec;47(6):1253-74. Review.

PMID:
11130995
16.

Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70.

Elder ME, Skoda-Smith S, Kadlecek TA, Wang F, Wu J, Weiss A.

J Immunol. 2001 Jan 1;166(1):656-61.

17.

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, Shapira SK, Farndon PA, Wara DW, Emmal SA, Ferguson BM.

Am J Hum Genet. 2000 Dec;67(6):1555-62. Epub 2000 Oct 24.

18.

Cytokine profile of a long-term pediatric HIV survivor with hyper-IgE syndrome and a normal CD4 T-cell count.

Seroogy CM, Wara DW, Bluth MH, Dorenbaum A, White C, Durkin HG, Elder ME.

J Allergy Clin Immunol. 1999 Nov;104(5):1045-51.

PMID:
10550751
19.

ZAP-70 and defects of T-cell receptor signaling.

Elder ME.

Semin Hematol. 1998 Oct;35(4):310-20. Review.

PMID:
9801260
20.

SCID due to ZAP-70 deficiency.

Elder ME.

J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):546-50. Review. No abstract available.

PMID:
9407944
Items per page

Supplemental Content

Loading ...
Write to the Help Desk